An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
This report contains market size and forecasts of Active Pharmaceutical Ingredients (API) in global, including the following market information:
Global Active Pharmaceutical Ingredients (API) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Active Pharmaceutical Ingredients (API) Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Active Pharmaceutical Ingredients (API) companies in 2021 (%)
The global Active Pharmaceutical Ingredients (API) market was valued at 74180 million in 2021 and is projected to reach US$ 113880 million by 2028, at a CAGR of 6.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Synthetic APIs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Active Pharmaceutical Ingredients (API) include Teva, Mylan, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer and Huahai Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Pharmaceutical Ingredients (API) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Pharmaceutical Ingredients (API) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Active Pharmaceutical Ingredients (API) Market Segment Percentages, by Type, 2021 (%)
- Synthetic APIs
- Biotech APIs
Global Active Pharmaceutical Ingredients (API) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Active Pharmaceutical Ingredients (API) Market Segment Percentages, by Application, 2021 (%)
- CNS
- Cardiovascular
- Genitourinary/Hormonal Drugs
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
Global Active Pharmaceutical Ingredients (API) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Active Pharmaceutical Ingredients (API) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Pharmaceutical Ingredients (API) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Active Pharmaceutical Ingredients (API) revenues share in global market, 2021 (%)
Key companies Active Pharmaceutical Ingredients (API) sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Active Pharmaceutical Ingredients (API) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teva
- Mylan
- DSM
- Aurobindo Pharma
- Aspen
- Novartis
- BASF
- Pfizer
- Huahai Pharmaceutical
- Hisun Pharmaceutical
- Sun Pharmaceutical Industries
- Zhejiang Medicine
- Dr. Reddy's Laboratories
- Zhejiang NHU
- Bayer
- NCPC
- AbbVie
- Shandong Xinhua Pharmaceutical
- Northeast Pharm
- Harbin Pharmaceutical
- LKPC
Active Pharmaceutical Ingredients (API) Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Active Pharmaceutical Ingredients (API) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Pharmaceutical Ingredients (API) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Pharmaceutical Ingredients (API) Overall Market Size
2.1 Global Active Pharmaceutical Ingredients (API) Market Size: 2021 VS 2028
2.2 Global Active Pharmaceutical Ingredients (API) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Active Pharmaceutical Ingredients (API) Sales: 2017-2028
3 Company Landscape
3.1 Top Active Pharmaceutical Ingredients (API) Players in Global Market
3.2 Top Global Active Pharmaceutical Ingredients (API) Companies Ranked by Revenue
3.3 Global Active Pharmaceutical Ingredients (API) Revenue by Companies
3.4 Global Active Pharmaceutical Ingredients (API) Sales by Companies
3.5 Global Active Pharmaceutical Ingredients (API) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Active Pharmaceutical Ingredients (API) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Active Pharmaceutical Ingredients (API) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) Players in Global Market
3.8.1 List of Global Tier 1 Active Pharmaceutical Ingredients (API) Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Active Pharmaceutical Ingredients (API) Market Size Markets, 2021 & 2028
4.1.2 Synthetic APIs
4.1.3 Biotech APIs
4.2 By Type - Global Active Pharmaceutical Ingredients (API) Revenue & Forecasts
4.2.1 By Type - Global Active Pharmaceutical Ingredients (API) Revenue, 2017-2022
4.2.2 By Type - Global Active Pharmaceutical Ingredients (API) Revenue, 2023-2028
4.2.3 By Type - Global Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
4.3 By Type - Global Active Pharmaceutical Ingredients (API) Sales & Forecasts
4.3.1 By Type - Global Active Pharmaceutical Ingredients (API) Sales, 2017-2022
4.3.2 By Type - Global Active Pharmaceutical Ingredients (API) Sales, 2023-2028
4.3.3 By Type - Global Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
4.4 By Type - Global Active Pharmaceutical Ingredients (API) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Active Pharmaceutical Ingredients (API) Market Size, 2021 & 2028
5.1.2 CNS
5.1.3 Cardiovascular
5.1.4 Genitourinary/Hormonal Drugs
5.1.5 Respiratory
5.1.6 Rheumatology
5.1.7 Diabetes
5.1.8 Oncology
5.1.9 Others
5.2 By Application - Global Active Pharmaceutical Ingredients (API) Revenue & Forecasts
5.2.1 By Application - Global Active Pharmaceutical Ingredients (API) Revenue, 2017-2022
5.2.2 By Application - Global Active Pharmaceutical Ingredients (API) Revenue, 2023-2028
5.2.3 By Application - Global Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
5.3 By Application - Global Active Pharmaceutical Ingredients (API) Sales & Forecasts
5.3.1 By Application - Global Active Pharmaceutical Ingredients (API) Sales, 2017-2022
5.3.2 By Application - Global Active Pharmaceutical Ingredients (API) Sales, 2023-2028
5.3.3 By Application - Global Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
5.4 By Application - Global Active Pharmaceutical Ingredients (API) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Active Pharmaceutical Ingredients (API) Market Size, 2021 & 2028
6.2 By Region - Global Active Pharmaceutical Ingredients (API) Revenue & Forecasts
6.2.1 By Region - Global Active Pharmaceutical Ingredients (API) Revenue, 2017-2022
6.2.2 By Region - Global Active Pharmaceutical Ingredients (API) Revenue, 2023-2028
6.2.3 By Region - Global Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
6.3 By Region - Global Active Pharmaceutical Ingredients (API) Sales & Forecasts
6.3.1 By Region - Global Active Pharmaceutical Ingredients (API) Sales, 2017-2022
6.3.2 By Region - Global Active Pharmaceutical Ingredients (API) Sales, 2023-2028
6.3.3 By Region - Global Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Active Pharmaceutical Ingredients (API) Revenue, 2017-2028
6.4.2 By Country - North America Active Pharmaceutical Ingredients (API) Sales, 2017-2028
6.4.3 US Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.4.4 Canada Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.4.5 Mexico Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Active Pharmaceutical Ingredients (API) Revenue, 2017-2028
6.5.2 By Country - Europe Active Pharmaceutical Ingredients (API) Sales, 2017-2028
6.5.3 Germany Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.5.4 France Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.5.5 U.K. Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.5.6 Italy Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.5.7 Russia Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.5.8 Nordic Countries Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.5.9 Benelux Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Active Pharmaceutical Ingredients (API) Revenue, 2017-2028
6.6.2 By Region - Asia Active Pharmaceutical Ingredients (API) Sales, 2017-2028
6.6.3 China Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.6.4 Japan Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.6.5 South Korea Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.6.6 Southeast Asia Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.6.7 India Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Active Pharmaceutical Ingredients (API) Revenue, 2017-2028
6.7.2 By Country - South America Active Pharmaceutical Ingredients (API) Sales, 2017-2028
6.7.3 Brazil Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.7.4 Argentina Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) Sales, 2017-2028
6.8.3 Turkey Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.8.4 Israel Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.8.5 Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
6.8.6 UAE Active Pharmaceutical Ingredients (API) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Active Pharmaceutical Ingredients (API) Major Product Offerings
7.1.4 Teva Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.1.5 Teva Key News
7.2 Mylan
7.2.1 Mylan Corporate Summary
7.2.2 Mylan Business Overview
7.2.3 Mylan Active Pharmaceutical Ingredients (API) Major Product Offerings
7.2.4 Mylan Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.2.5 Mylan Key News
7.3 DSM
7.3.1 DSM Corporate Summary
7.3.2 DSM Business Overview
7.3.3 DSM Active Pharmaceutical Ingredients (API) Major Product Offerings
7.3.4 DSM Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.3.5 DSM Key News
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Corporate Summary
7.4.2 Aurobindo Pharma Business Overview
7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Major Product Offerings
7.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.4.5 Aurobindo Pharma Key News
7.5 Aspen
7.5.1 Aspen Corporate Summary
7.5.2 Aspen Business Overview
7.5.3 Aspen Active Pharmaceutical Ingredients (API) Major Product Offerings
7.5.4 Aspen Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.5.5 Aspen Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Active Pharmaceutical Ingredients (API) Major Product Offerings
7.6.4 Novartis Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.6.5 Novartis Key News
7.7 BASF
7.7.1 BASF Corporate Summary
7.7.2 BASF Business Overview
7.7.3 BASF Active Pharmaceutical Ingredients (API) Major Product Offerings
7.7.4 BASF Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.7.5 BASF Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Active Pharmaceutical Ingredients (API) Major Product Offerings
7.8.4 Pfizer Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Key News
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Corporate Summary
7.9.2 Huahai Pharmaceutical Business Overview
7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Major Product Offerings
7.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.9.5 Huahai Pharmaceutical Key News
7.10 Hisun Pharmaceutical
7.10.1 Hisun Pharmaceutical Corporate Summary
7.10.2 Hisun Pharmaceutical Business Overview
7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Major Product Offerings
7.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.10.5 Hisun Pharmaceutical Key News
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Corporate Summary
7.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Business Overview
7.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.11.5 Sun Pharmaceutical Industries Key News
7.12 Zhejiang Medicine
7.12.1 Zhejiang Medicine Corporate Summary
7.12.2 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Business Overview
7.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Major Product Offerings
7.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.12.5 Zhejiang Medicine Key News
7.13 Dr. Reddy's Laboratories
7.13.1 Dr. Reddy's Laboratories Corporate Summary
7.13.2 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Business Overview
7.13.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Major Product Offerings
7.13.4 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.13.5 Dr. Reddy's Laboratories Key News
7.14 Zhejiang NHU
7.14.1 Zhejiang NHU Corporate Summary
7.14.2 Zhejiang NHU Business Overview
7.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Major Product Offerings
7.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.14.5 Zhejiang NHU Key News
7.15 Bayer
7.15.1 Bayer Corporate Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Active Pharmaceutical Ingredients (API) Major Product Offerings
7.15.4 Bayer Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.15.5 Bayer Key News
7.16 NCPC
7.16.1 NCPC Corporate Summary
7.16.2 NCPC Business Overview
7.16.3 NCPC Active Pharmaceutical Ingredients (API) Major Product Offerings
7.16.4 NCPC Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.16.5 NCPC Key News
7.17 AbbVie
7.17.1 AbbVie Corporate Summary
7.17.2 AbbVie Business Overview
7.17.3 AbbVie Active Pharmaceutical Ingredients (API) Major Product Offerings
7.17.4 AbbVie Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.17.5 AbbVie Key News
7.18 Shandong Xinhua Pharmaceutical
7.18.1 Shandong Xinhua Pharmaceutical Corporate Summary
7.18.2 Shandong Xinhua Pharmaceutical Business Overview
7.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Major Product Offerings
7.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.18.5 Shandong Xinhua Pharmaceutical Key News
7.19 Northeast Pharm
7.19.1 Northeast Pharm Corporate Summary
7.19.2 Northeast Pharm Business Overview
7.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Major Product Offerings
7.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.19.5 Northeast Pharm Key News
7.20 Harbin Pharmaceutical
7.20.1 Harbin Pharmaceutical Corporate Summary
7.20.2 Harbin Pharmaceutical Business Overview
7.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Major Product Offerings
7.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.20.5 Harbin Pharmaceutical Key News
7.21 LKPC
7.21.1 LKPC Corporate Summary
7.21.2 LKPC Business Overview
7.21.3 LKPC Active Pharmaceutical Ingredients (API) Major Product Offerings
7.21.4 LKPC Active Pharmaceutical Ingredients (API) Sales and Revenue in Global (2017-2022)
7.21.5 LKPC Key News
8 Global Active Pharmaceutical Ingredients (API) Production Capacity, Analysis
8.1 Global Active Pharmaceutical Ingredients (API) Production Capacity, 2017-2028
8.2 Active Pharmaceutical Ingredients (API) Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Pharmaceutical Ingredients (API) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Active Pharmaceutical Ingredients (API) Supply Chain Analysis
10.1 Active Pharmaceutical Ingredients (API) Industry Value Chain
10.2 Active Pharmaceutical Ingredients (API) Upstream Market
10.3 Active Pharmaceutical Ingredients (API) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Pharmaceutical Ingredients (API) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Active Pharmaceutical Ingredients (API) in Global Market
Table 2. Top Active Pharmaceutical Ingredients (API) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Active Pharmaceutical Ingredients (API) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Active Pharmaceutical Ingredients (API) Revenue Share by Companies, 2017-2022
Table 5. Global Active Pharmaceutical Ingredients (API) Sales by Companies, (Tons), 2017-2022
Table 6. Global Active Pharmaceutical Ingredients (API) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Active Pharmaceutical Ingredients (API) Price (2017-2022) & (USD/Ton)
Table 8. Global Manufacturers Active Pharmaceutical Ingredients (API) Product Type
Table 9. List of Global Tier 1 Active Pharmaceutical Ingredients (API) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Active Pharmaceutical Ingredients (API) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Active Pharmaceutical Ingredients (API) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Active Pharmaceutical Ingredients (API) Sales (Tons), 2017-2022
Table 15. By Type - Global Active Pharmaceutical Ingredients (API) Sales (Tons), 2023-2028
Table 16. By Application - Global Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Active Pharmaceutical Ingredients (API) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Active Pharmaceutical Ingredients (API) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Active Pharmaceutical Ingredients (API) Sales (Tons), 2017-2022
Table 20. By Application - Global Active Pharmaceutical Ingredients (API) Sales (Tons), 2023-2028
Table 21. By Region - Global Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Active Pharmaceutical Ingredients (API) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Active Pharmaceutical Ingredients (API) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Active Pharmaceutical Ingredients (API) Sales (Tons), 2017-2022
Table 25. By Region - Global Active Pharmaceutical Ingredients (API) Sales (Tons), 2023-2028
Table 26. By Country - North America Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Active Pharmaceutical Ingredients (API) Sales, (Tons), 2017-2022
Table 29. By Country - North America Active Pharmaceutical Ingredients (API) Sales, (Tons), 2023-2028
Table 30. By Country - Europe Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Active Pharmaceutical Ingredients (API) Sales, (Tons), 2017-2022
Table 33. By Country - Europe Active Pharmaceutical Ingredients (API) Sales, (Tons), 2023-2028
Table 34. By Region - Asia Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Active Pharmaceutical Ingredients (API) Sales, (Tons), 2017-2022
Table 37. By Region - Asia Active Pharmaceutical Ingredients (API) Sales, (Tons), 2023-2028
Table 38. By Country - South America Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Active Pharmaceutical Ingredients (API) Sales, (Tons), 2017-2022
Table 41. By Country - South America Active Pharmaceutical Ingredients (API) Sales, (Tons), 2023-2028
Table 42. By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) Sales, (Tons), 2017-2022
Table 45. By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) Sales, (Tons), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Active Pharmaceutical Ingredients (API) Product Offerings
Table 48. Teva Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 49. Mylan Corporate Summary
Table 50. Mylan Active Pharmaceutical Ingredients (API) Product Offerings
Table 51. Mylan Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 52. DSM Corporate Summary
Table 53. DSM Active Pharmaceutical Ingredients (API) Product Offerings
Table 54. DSM Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 55. Aurobindo Pharma Corporate Summary
Table 56. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Offerings
Table 57. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 58. Aspen Corporate Summary
Table 59. Aspen Active Pharmaceutical Ingredients (API) Product Offerings
Table 60. Aspen Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 61. Novartis Corporate Summary
Table 62. Novartis Active Pharmaceutical Ingredients (API) Product Offerings
Table 63. Novartis Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 64. BASF Corporate Summary
Table 65. BASF Active Pharmaceutical Ingredients (API) Product Offerings
Table 66. BASF Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer Active Pharmaceutical Ingredients (API) Product Offerings
Table 69. Pfizer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 70. Huahai Pharmaceutical Corporate Summary
Table 71. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
Table 72. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 73. Hisun Pharmaceutical Corporate Summary
Table 74. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
Table 75. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 76. Sun Pharmaceutical Industries Corporate Summary
Table 77. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Offerings
Table 78. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 79. Zhejiang Medicine Corporate Summary
Table 80. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Offerings
Table 81. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 82. Dr. Reddy's Laboratories Corporate Summary
Table 83. Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Product Offerings
Table 84. Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 85. Zhejiang NHU Corporate Summary
Table 86. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Offerings
Table 87. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 88. Bayer Corporate Summary
Table 89. Bayer Active Pharmaceutical Ingredients (API) Product Offerings
Table 90. Bayer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 91. NCPC Corporate Summary
Table 92. NCPC Active Pharmaceutical Ingredients (API) Product Offerings
Table 93. NCPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 94. AbbVie Corporate Summary
Table 95. AbbVie Active Pharmaceutical Ingredients (API) Product Offerings
Table 96. AbbVie Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 97. Shandong Xinhua Pharmaceutical Corporate Summary
Table 98. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
Table 99. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 100. Northeast Pharm Corporate Summary
Table 101. Northeast Pharm Active Pharmaceutical Ingredients (API) Product Offerings
Table 102. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 103. Harbin Pharmaceutical Corporate Summary
Table 104. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Offerings
Table 105. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 106. LKPC Corporate Summary
Table 107. LKPC Active Pharmaceutical Ingredients (API) Product Offerings
Table 108. LKPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Average Price (USD/Ton) (2017-2022)
Table 109. Active Pharmaceutical Ingredients (API) Production Capacity (Tons) of Key Manufacturers in Global Market, 2020-2022 (Tons)
Table 110. Global Active Pharmaceutical Ingredients (API) Capacity Market Share of Key Manufacturers, 2020-2022
Table 111. Global Active Pharmaceutical Ingredients (API) Production by Region, 2017-2022 (Tons)
Table 112. Global Active Pharmaceutical Ingredients (API) Production by Region, 2023-2028 (Tons)
Table 113. Active Pharmaceutical Ingredients (API) Market Opportunities & Trends in Global Market
Table 114. Active Pharmaceutical Ingredients (API) Market Drivers in Global Market
Table 115. Active Pharmaceutical Ingredients (API) Market Restraints in Global Market
Table 116. Active Pharmaceutical Ingredients (API) Raw Materials
Table 117. Active Pharmaceutical Ingredients (API) Raw Materials Suppliers in Global Market
Table 118. Typical Active Pharmaceutical Ingredients (API) Downstream
Table 119. Active Pharmaceutical Ingredients (API) Downstream Clients in Global Market
Table 120. Active Pharmaceutical Ingredients (API) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Active Pharmaceutical Ingredients (API) Segment by Type
Figure 2. Active Pharmaceutical Ingredients (API) Segment by Application
Figure 3. Global Active Pharmaceutical Ingredients (API) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Active Pharmaceutical Ingredients (API) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Active Pharmaceutical Ingredients (API) Revenue, 2017-2028 (US$, Mn)
Figure 7. Active Pharmaceutical Ingredients (API) Sales in Global Market: 2017-2028 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2021
Figure 9. By Type - Global Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
Figure 10. By Type - Global Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Active Pharmaceutical Ingredients (API) Price (USD/Ton), 2017-2028
Figure 12. By Application - Global Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
Figure 13. By Application - Global Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Active Pharmaceutical Ingredients (API) Price (USD/Ton), 2017-2028
Figure 15. By Region - Global Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
Figure 16. By Region - Global Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
Figure 19. US Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
Figure 24. Germany Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 25. France Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
Figure 33. China Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 37. India Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
Figure 40. Brazil Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share, 2017-2028
Figure 44. Turkey Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Active Pharmaceut
Dextran - Global Market Insights and Sales Trends 2024 -2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 122
The global Dextran market was valued at US$ 234.14 million in 2022 and it will reach US$ 346.64 million by the end of 2029, growing at a CAGR of 5.97% during 2023-2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dextran, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed bu......
Global Corticosteroids API Market Research Report 2023
Published: 11-Jan-2024 Price: US 2900 Onwards Pages: 162
The global Corticosteroids API market was valued at US$ 2206.26 million in 2022 and is anticipated to reach US$ 3309.40 million by 2029, witnessing a CAGR of 6.11% during the forecast period 2023-2029.
North American market for Corticosteroids API is estimated to increase from $ 220.53 million in 2022 to reach $ 302.18 million by 2029, at a CAGR of 4.69 % during the forecast period of 2023 through 2029.
Europe market for Corticosteroids API is estimated to increase from $ 512.79 mi......
Global HPLC Columns Market Research Report 2023
Published: 11-Jan-2024 Price: US 2900 Onwards Pages: 149
The global HPLC Columns market was valued at US$ 1823.16 million in 2022 and is anticipated to reach US$ 2674.78 million by 2029, witnessing a CAGR of 6.37% during the forecast period 2023-2029.
The major global manufacturers of HPLC Columns include Agilent, Waters Corporation, Shimadzu, Thermo Fisher Scientific, Danaher, Hamilton, Merck, Bio - Rad, and Restek, etc. In 2022, the world's top three vendors accounted for approximately 48.41 % of the revenue.
Report Scope
This r......
Global Inorganic Advanced Phase Change Materials Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Inorganic Advanced Phase Change Materials market was valued at US$ 960.3 million in 2023 and is anticipated to reach US$ 2087.3 million by 2030, witnessing a CAGR of 11.9% during The forecast period 2024-2030.
North American market for Inorganic Advanced Phase Change Materials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Inorganic Advanced Phase Ch......
Global Material Jetting 3D Printing Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 88
The global Material Jetting 3D Printing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Material Jetting 3D Printing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Material Jetting 3D Printing is estimated to increase from $ million i......
Global Halogen Free Material Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 81
The global Halogen Free Material market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Halogen Free Material is estimated to increase from $ million in 2023 to reach $ mil......
Global Silicone Adhesives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 101
The global Silicone Adhesives market was valued at US$ 1999.8 million in 2023 and is anticipated to reach US$ 2628.8 million by 2030, witnessing a CAGR of 3.5% during The forecast period 2024-2030.
North American market for Silicone Adhesives is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Silicone Adhesives is estimated to increase from $ million in 2023 to rea......
Global Paraffin Hydrotreating Catalyst Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 91
The global Paraffin Hydrotreating Catalyst market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Paraffin Hydrotreating Catalyst is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Paraffin Hydrotreating Catalyst is estimated to increase from $ ......
Global Stained Glass Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Stained Glass market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Stained Glass is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
